VEA
ANIP icon

Virtus ETF Advisers’s ANI Pharmaceuticals ANIP Stock Holding History

Virtus ETF Advisers’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Sell
13,556
-2,350
-15% -$183K 0.48% 41
2025
Q4 		$1.26M Hold
15,906
– – 0.59% 31
2025
Q3 		$1.46M Hold
15,906
– – 0.8% 25
2025
Q2 		$1.04M Buy
15,906
+2,135
+16% +$139K 0.63% 33
2025
Q1 		$922K Buy
+13,771
New +$823K 0.6% 34

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Virtus ETF Advisers's ANIP Position: Q1 2026 in Review

Virtus ETF Advisers reduced its ANI Pharmaceuticals (ANIP) stake by 15% in Q1 2026, selling an estimated $183K and leaving 13,556 shares worth $1.04M. The position accounts for 0.48% of the portfolio, ranked #41.

Virtus ETF Advisers first reported a position in ANIP in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.46M in Q3 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Virtus ETF Advisers held 13,556 shares of ANI Pharmaceuticals worth $1.04M as of Q1 2026.
  • Virtus ETF Advisers sold 2,350 ANI Pharmaceuticals shares in Q1 2026, an estimated $183K.
  • ANI Pharmaceuticals made up 0.48% of Virtus ETF Advisers's portfolio in Q1 2026, its #41 holding.
  • Virtus ETF Advisers first reported a position in ANI Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Virtus ETF Advisers's ANI Pharmaceuticals position peaked at $1.46M in Q3 2025.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Virtus ETF Advisers's 13F filing for Q1 2026, filed 14 May 2026.